Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Extra stomach cancer indication for Cyramza in US

FDA backs Lilly drug in combination with paclitaxel chemotherapy

- PMLiVE

Vertex submits Kalydeco combo for cystic fibrosis

Seeks approval in both US and Europe

- PMLiVE

GSK first to file IL-5 antagonist for asthma

Mepolizumab submitted as a treatment for severe eosinophilic asthma

- PMLiVE

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient...

- PMLiVE

New CEO for Grayling Germany

Frank Schönrock joins from Grünenthal

- PMLiVE

Publicis Healthcare appoints global business development head

Rick Keefer was CEO of Publicis Touchpoint Solutions

- PMLiVE

Power to the people: an era of self-care

Pharma should consider what a patient-centric approach to care really means

- PMLiVE

Astellas EMEA CEO volunteers at school

Ken Jones promotes healthy lifestyle as part of Changing Tomorrow campaign

- PMLiVE

Amgen’s trebananib misses survival target in ovarian cancer

First phase III trial improved survival rates by just one month

Merck KGaA’s Oschmann elected president of IFPMA

He takes over from Lilly’s John Lechleiter

Roche - Basel

Roche invests in diagnostics in China

Commits 450m Swiss francs to manufacturing facility

- PMLiVE

Lundbeck still feeling effects from Cipralex patent loss

The antidepressant sales dropped another 33% in the third quarter

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links